<DOC>
	<DOC>NCT00056459</DOC>
	<brief_summary>To compare treatment with oxaliplatin/5-FU/leucovorin plus vatalanib versus oxaliplatin/5-FU/leucovorin plus placebo in patients with colorectal cancer that has spread to other organs and are seeking first chemotherapy treatment</brief_summary>
	<brief_title>Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Metastatic Colorectal Cancer.</brief_title>
	<detailed_description />
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Rectal Neoplasms</mesh_term>
	<mesh_term>Colonic Neoplasms</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<mesh_term>Vatalanib</mesh_term>
	<criteria>Inclusion criteria: Patients with metastatic colorectal cancer coming for initial chemotherapy Documented metastatic colorectal cancer WHO Performance Status of 0, 1, or 2 Measurable tumors Adequate hematologic status, liver and kidney function Life expectancy greater than 12 weeks Written informed consent obtained Exclusion criteria: History or presence of central nervous system disease Patients with a history of another primary cancer within 5 years Prior chemotherapy for metastatic colorectal cancer Prior full field radiotherapy within 4 weeks or limited field radiotherapy within 2 weeks before entry to study Major surgery within 4 weeks or minor surgery within 2 weeks before entry to study Investigational drugs within 4 weeks before entry to study Prior therapy with antiVEGF agents Any prior therapy with oxaliplatin or allergy to platinumcontaining drugs Peripheral neuropathy with functional impairment Female patients who are pregnant or breast feeding Any severe or uncontrolled medical conditions which could prevent participation in study Patients who are taking Coumadin Other protocoldefined inclusion / exclusion criteria may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2009</verification_date>
	<keyword>Colorectal Cancer</keyword>
	<keyword>PTK787</keyword>
	<keyword>Vatalanib</keyword>
	<keyword>VEGF inhibitor</keyword>
	<keyword>Oxaliplatin</keyword>
	<keyword>Angiogenesis</keyword>
	<keyword>Rectal Cancer</keyword>
	<keyword>Colon Cancer</keyword>
	<keyword>Colorectal Carcinoma</keyword>
	<keyword>Colorectal Tumor</keyword>
</DOC>